Xin Liang a , Hong Xie b , Pei-Hong Zhu b , Jun Hu a, d , Qiang Zhao c , Chun-Sheng Wang c , Cheng Yang c
31 March 2008
Atrial fibrillation, Ca2+ sparks, Ca2+ waves, Ryanodine receptor, Sarcoplasmic reticulum
Background: Many alterations in sarcoplasmic reticulum Ca<sup>2+</sup> handling proteins in atrial myocytes have been associated with atrial fibrillation (AF) in clinical patients, whereas the functional consequences of these alterations mostly remain unclear. Methods and Results: To know whether or not ryanodine receptor (RyR)-mediated intracellular Ca<sup>2+</sup> events in AF atrial myocytes are affected by protein alterations, we investigated spontaneous Ca<sup>2+</sup> sparks and Ca<sup>2+</sup> waves in intact and permeabilized atrial myocytes of AF patients (n<sub>patients</sub> = 21) and normal sinus rhythm (NSR) patients (n<sub>patients</sub> = 22) by laser scanning confocal microscopy. It was found that the frequency, amplitude and rise time of Ca<sup>2+</sup> sparks were comparable between AF and NSR groups, while full width and full duration at half maximum intensity significantly increased in the AF group. Along with these changes, the frequency of small and global Ca<sup>2+</sup> waves increased in AF atrial myocytes. Conclusions: Our results clearly indicated that the spatiotemporal properties but not the frequency of Ca<sup>2+</sup> sparks were affected in AF atrial myocytes. In addition, the frequency of Ca<sup>2+</sup> waves increased. This profile of the alterations in RyR-mediated Ca<sup>2+</sup> events in AF atrial myocytes was different from previous studies. The underlying mechanisms, as well as possible reasons for this discrepancy, were discussed.
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.